Flavopiridol in Treating Patients With Recurrent Prostate Cancer

Completed · Phase 2

Conditions studied: Prostate Cancer

In brief

Phase II trial to study the effectiveness of flavopiridol in treating patients with recurrent prostate cancer after hormone therapy. Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.

Key facts

Study ID

NCT00003256

Run by

National Cancer Institute (NCI)

People needed

40

Starts

1998-05-01

Expected to finish

2004-04-01

Last updated by the study team

2013-02-11

Who can join

Age: any. Sex: male. Healthy volunteers: not accepted.

Where it is running

• Beckman Research Institute, City of Hope — Duarte, California, United States
• University of California Davis Cancer Center — Sacramento, California, United States
• Dana-Farber Cancer Institute — Boston, Massachusetts, United States
• University of Wisconsin Comprehensive Cancer Center — Madison, Wisconsin, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.